Views & Analysis High-value, high-cost drugs: how to pay for them Experts call for urgent development of new drug funding mechanisms.
Views & Analysis Tunnah’s musings: Hope over hype for pharma in patient centr... Three areas where the pharma industry will advance in 2017 as it looks beyond the hype.
Events Partner Content Making Pharmaceuticals 25 & 26 April 2017 Exhibition & Conference for Pharma Professionals
Views & Analysis Unified systems mean faster clinical trials Inefficient processes, legacy infrastructure and a silo culture are slowing access to critical trial data.
Views & Analysis How can pharma help NHS improve mental health services? Sustainability and Transformation Plans present an opportunity for pharma to support research into mental health conditions.
Views & Analysis From treatment to technology: a personal journey William King, founder and executive chairman of Zephyr Health, on using predictive insights for business transformation.
News CMS aims for broader GLP-1 access via federal programmes CMS has revealed a new, voluntary access programme that aims to broaden the use of GLP-1 agonist medicines for diabetes and obesity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
